10:52 AM EDT, 10/03/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher Friday morning, rising 0.67% to 1,597.70 on the S&P Europe Select ADR Index, which surged 3.3% for the week.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Cellectis ( CLLS ) , which advanced 8.6% and 3.8%, respectively. They were followed by internet advertising firm Criteo ( CRTO ) and biotech company Evaxion ( EVAX ) , which increased 2.8% and 2.3%, respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and medical device maker EDAP TMS ( EDAP ) , which fell 1.5% each. They were followed by software firm SAP (SAP) and brewing company Anheuser-Busch InBev ( BUD ) , which were down 1.1% each.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and NuCana ( NCNA ) , which rose 8.4% and 4.5%, respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Amarin ( AMRN ) , which were up 3.7% and 3.6%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and insurance company Prudential (PUK), which lost 1.6% and 0.8%, respectively. They were followed by pharmaceutical company GSK (GSK) and biopharmaceutical company Bicycle Therapeutics ( BCYC ) , which dropped 0.6% and 0.5%, respectively.